Skip to main content

All industries

2087 results for All industries
Filters
Refine your search
Manufacturer
Brand Name
CLEAR ALL
Actylis
Coating agent developed for solid and semi-solid dosage forms.Benefits:
  • Strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
Actylis
Coating agent developed for solid and semi-solid dosage forms.Benefits:
  • Strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
Actylis
Excipient developed for use in pharmaceutical applications.
Actylis
Excipient designed for use in pharmaceutical applications.
Actylis
Excipient designed for use in pharmaceutical applications.
Actylis
Excipient for use in pharmaceutical applications.
Actylis
Excipient for use in pharmaceutical applications.
Actylis
Excipient recommended for pharmaceutical applications.
Actylis
Excipient applicable in pharmaceutical applications.
Actylis
Solvent/ Co-solvent developed exclusively for use in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20190000639
Actylis
Solvent/ Co-solvent developed exclusively for use in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20190000639
Actylis
Solvent, co-solvent and chelating agent designed for injectable formulations.Benefits:
  • Helps to maintain low level of endotoxins and metallic impurities
  • Compliant with USP and Ph. Eur
Actylis
Solvent, co-solvent and chelating agent designed for injectable formulations.Benefits:
  • Helps to maintain low level of endotoxins and metallic impurities
  • Compliant with USP and Ph. Eur
Actylis
Solvent, co-solvent and chelating agent designed for injectable formulations.Benefits:
  • Helps to maintain low level of endotoxins and metallic impurities
  • Compliant with USP and Ph. Eur
Actylis
Solvent/ Co-solvent and chelating agent developed exclusively for use in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • Strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
Actylis
Solvent and permeation enhancer designed for transdermal patches and oral solid dosage formulas.Benefits:
  • Highly pure, improves drug efficacy by increasing skin permeation
  • Compliant with USP and Ph. Eur